Dohyub Jang

Dohyub Jang

Auto-generated profile, based on publicly available information

Dohyub Jang

Chemical and Biological Integrative Research Center Korea Institute of Science and Technology 5 Hwarang‐ro 14‐Gil, Seongbuk‐gu Seoul 02792 Republic of Korea

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 December 2021 in ACS Applied Materials & Interfaces
Verified
Journal Article
Closed access
SYSubin Yu
Subin Yu
DJDohyub Jang
Dohyub Jang
HYHong Yuan
Hong Yuan
WHWen-Tse Huang
Wen-Tse Huang
MKMinju Kim
Minju Kim
Dong Ha KimDong Ha Kim
Dong Ha Kim

22 April 2022 in ACS Omega
Verified
Journal Article
Open access
SMSwarup Kumar Maji
Swarup Kumar Maji
SYSubin Yu
Subin Yu
ECEunshil Choi
Eunshil Choi
Ju Won LimJu Won Lim
Ju Won Lim
DJDohyub Jang
Dohyub Jang
Dong Ha KimDong Ha Kim
Dong Ha Kim
The unique physicochemical and localized surface plasmon resonance assets of gold nanorods (GNRs) have offered combined cancer treatments with real-time diagnosis by integrating diverse theragnostic modalities into a single nanoplatform. In this work, a unique multifunctional nanohybrid material based on GNRs was designed for in vitro and in vivo tumor imaging along with synergistic and combinatorial therapy of tumor. The hybrid material with size less than 100 nm was achieved by embedding indocyanine green (ICG) on mesoporous silica-coated GNRs with further wrapping of reduced graphene oxide (rGO) and then attached with doxorubicin (DOX) and polyethylene glycol. The nanohybrid unveiled noteworthy stability and competently protected the embedded ICG from further aggregation, photobleaching, and nucleophilic attack by encapsulation of GNRs-ICG with rGO. Such combination of GNRs-ICG with rGO and DOX served as a real-time near-infrared (NIR) contrast imaging agent for cancer diagnosis. The hybrid material exhibits high NIR absorption property along with three destined capabilities, such as, nanozymatic activity, photothermal activity, and an excellent drug carrier for drug delivery. The integrated properties of the nanohybrid were then utilized for the triple mode of combined therapeutics of tumor cells, through synergistic catalytic therapy and chemotherapy with combinatorial photothermal therapy to achieve the maximum cancer killing efficiency. It is assumed that the assimilated multimodal imaging and therapeutic capability in single nanoparticle platform is advantageous for future practical applications in cancer diagnosis, therapy, and molecular imaging.

4 October 2021 in ACS Nano
Verified
Journal Article
Closed access
KJKeunsoo Jeong
Keunsoo Jeong
DKDojin Kim
Dojin Kim
HKHyun Jun Kim
Hyun Jun Kim
YLYong-Deok Lee
Yong-Deok Lee
JYJounghyun Yoo
Jounghyun Yoo
SKSehoon Kim
Sehoon Kim

26 January 2021 in Chemical Communications
Verified
Journal Article
Closed access
PDF file
YNYoonseo Nah
Yoonseo Nah
DJDohyub Jang
Dohyub Jang
Dong Ha KimDong Ha Kim
Dong Ha Kim
We report a distinct method for the production of organic–inorganic hybrid perovskite (OIHP) nanostructures using block copolymer micelles as scaffolds.

21 January 2024 in Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy
Verified
Journal Article
Closed access
YSYoung Hun Seo
Young Hun Seo
DEDiana Elizabeth Aguilar Estrada
Diana Elizabeth Aguilar Estrada
DJDohyub Jang
Dohyub Jang
SBSeungyun Baik
Seungyun Baik
JLJaeho Lee
Jaeho Lee
SKSehoon Kim
Sehoon Kim

21 May 2025 in Advanced Materials
Verified
Journal Article
Open access
DLDohee Lee
Dohee Lee
HJHeung Jin Jeon
Heung Jin Jeon
DJDohyub Jang
Dohyub Jang
Deukhee LeeDeukhee Lee
Deukhee Lee
SKSolbi Kim
Solbi Kim
SSSeungBeum Suh
SeungBeum Suh
Current imaging techniques suffer from a lack of specificity and resolution, leading to inaccurate tumor imaging and limited applicability of targeted contrast agents, as they require cancer‐specific development. The need for enhanced contrast through improved tumor‐to‐background ratio (TBR) and the toxicity from repeated injections due to fading fluorescent signals further complicate the issue. Additionally, challenges in visualizing the entire 3D tumor with surface‐stained contrast agents highlight the demand for advanced imaging solutions for more precise surgical guidance. A novel approach is proposed utilizing Streptavidin Associated Salmonella (SAS) as a contrast agent for image‐guided surgeries. SAS selectively proliferates in cancerous tissues and secretes streptavidin upon induction, enabling the binding of subsequently injected biotin‐conjugated fluorescent dyes. This approach enhances tumor visualization with a TBR of up to 15.3, far surpassing conventional agents (TBR ∼ 2), while enabling prolonged 3‐day imaging, deep tumor penetration, and precise invasive margin delineation with a single contrast agent injection. Furthermore, biosafety evaluations confirmed efficient bacterial clearance, absence of systemic toxicity, and stable physiological responses, supporting its potential for safe clinical translation. This innovative method offers substantial improvements over existing fluorescent contrast agents and holds promise for both diagnostic and therapeutic applications in cancer surgery.